KEY vs STRO
KeyCorp (KEY) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the KEY and STRO stock pages for the full models.
Not investment advice.